7月16日，ASMPT盘中下跌5.99%，报179.9港元，成交额9756.5万港元。
消息面上，高盛近日虽将ASMPT目标价由118.3港元大幅上调至206港元，但维持"中性"评级，明确指出正面因素已大致反映在股价表现上。与此同时，机构减持压力持续：The Capital Group于7月9日减持81.11万股，持股比例降至9.82%；贝莱德持股比例亦从6.13%降至5.48%；南向资金连续多日净卖出，近5个交易日累计净减持322.86万股。公司将于7月28日召开董事会审议中期业绩，业绩窗口期前的不确定性叠加机构集中减仓，对短期股价形成明显压力。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.